DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
Clinical trial NCT03825315 · COMPLETED
Trial details
- NCT number
- NCT03825315
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-31
- Primary completion
- 2020-06-04
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.